OXIMED 0.255mg / 0.085mg suspension skin spray medication leaflet

D07CA01 oxytetracycline + hydrocortisone • Dermatologicals | Corticosteroids, combinations with antibiotics | Corticosteroids, weak, combinations with antibiotics

The combination of oxytetracycline and hydrocortisone is used in the treatment of bacterial skin infections accompanied by inflammation. Oxytetracycline is a broad-spectrum antibiotic that inhibits bacterial growth, while hydrocortisone is a corticosteroid that reduces inflammation and itching.

The medication is applied topically, as directed by a doctor, usually two to three times daily to the affected area. It is important for patients to follow the treatment duration to prevent recurrence of the infection.

Patients should be aware of potential side effects, such as local irritation, skin dryness, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include local irritation and skin dryness. In rare cases, severe reactions such as hypersensitivity or secondary infections may occur. Patients should be informed of these risks before use.

General data about OXIMED 0.255mg / 0.085mg

Substance: oxytetracycline + hydrocortisone

Date of last drug list: 01-10-2014

Commercial code: W01888001

Concentration: 0.255mg / 0.085mg

Pharmaceutical form: suspension skin spray

Quantity: 1

Product type: generic

Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

Manufacturer: MEBRA SRL - ROMANIA

Holder: MEBRA SRL - ROMANIA

Number: 5285/2005/01

Shelf life: 2 years